UroGen Pharma
URGN
URGN
86 hedge funds and large institutions have $473M invested in UroGen Pharma in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 40 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less call options, than puts
Call options by funds: $8.04M | Put options by funds: $8.55M
2.09% less ownership
Funds ownership: 69.69% → 67.6% (-2.1%)
Holders
86
Holding in Top 10
2
Calls
$8.04M
Puts
$8.55M
Top Buyers
| 1 | +$5.48M | |
| 2 | +$5.1M | |
| 3 | +$4.17M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$4M |
| 5 |
WCM
Wildcat Capital Management
New York
|
+$3.33M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$9.13M | |
| 3 | -$8M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$3.59M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.2M |